Bar Harbor Trust Services Lowers stake in Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ) : Bar Harbor Trust Services reduced its stake in Johnson & Johnson by 2.55% during the most recent quarter end. The investment management company now holds a total of 96,582 shares of Johnson & Johnson which is valued at $10,824,911 after selling 2,531 shares in Johnson & Johnson , the firm said in a disclosure report filed with the SEC on Apr 26, 2016.Johnson & Johnson makes up approximately 6.19% of Bar Harbor Trust Services’s portfolio.

Johnson & Johnson opened for trading at $112.22 and hit $112.7897 on the upside on Monday, eventually ending the session at $112.75, with a gain of 0.60% or 0.67 points. The heightened volatility saw the trading volume jump to 51,78,847 shares. Company has a market cap of $311,118 M.

Other Hedge Funds, Including , Concorde Asset Management boosted its stake in JNJ in the latest quarter, The investment management firm added 973 additional shares and now holds a total of 3,811 shares of Johnson & Johnson which is valued at $427,137. Johnson & Johnson makes up approx 0.49% of Concorde Asset Management’s portfolio.Calamos Advisors boosted its stake in JNJ in the latest quarter, The investment management firm added 45,026 additional shares and now holds a total of 1,193,771 shares of Johnson & Johnson which is valued at $133,797,854. Johnson & Johnson makes up approx 1.19% of Calamos Advisors’s portfolio.Tufton Capital Management boosted its stake in JNJ in the latest quarter, The investment management firm added 207 additional shares and now holds a total of 93,877 shares of Johnson & Johnson which is valued at $10,343,368. Johnson & Johnson makes up approx 2.56% of Tufton Capital Management’s portfolio.Bkd Wealth Advisors boosted its stake in JNJ in the latest quarter, The investment management firm added 150 additional shares and now holds a total of 32,958 shares of Johnson & Johnson which is valued at $3,631,312. Johnson & Johnson makes up approx 0.57% of Bkd Wealth Advisors’s portfolio.Capstone Asset Management Co boosted its stake in JNJ in the latest quarter, The investment management firm added 1,921 additional shares and now holds a total of 78,247 shares of Johnson & Johnson which is valued at $8,621,254. Johnson & Johnson makes up approx 0.25% of Capstone Asset Management Co’s portfolio.

On the company’s financial health, Johnson & Johnson reported $1.68 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Apr 19, 2016. Analyst had a consensus of $1.65. The company had revenue of $17482.00 million for the quarter, compared to analysts expectations of $17491.02 million. The company’s revenue was up .6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.56 EPS.

Many Wall Street Analysts have commented on Johnson & Johnson. Company shares were Reiterated by RBC Capital Mkts on Apr 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 125 from a previous price target of $122 .Company shares were Reiterated by Piper Jaffray on Apr 20, 2016 to “Neutral”, Firm has raised the Price Target to $ 106 from a previous price target of $105 .Company shares were Reiterated by RBC Capital Mkts on Apr 15, 2016 to “Outperform”, Firm has raised the Price Target to $ 122 from a previous price target of $114 .

Johnson & Johnson is a holding company. The Company is engaged in the research and development manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Company’s primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer Pharmaceutical and Medical Devices. The Company’s subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Company’s research facilities are located in the United States Belgium Brazil Canada China France Germany India Israel Japan the Netherlands Singapore Switzerland and the United Kingdom.

Leave a Reply

Johnson & Johnson - Is it time to Sell?

Top Brokerage Firms are advising their investors on Johnson & Johnson. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.